LTF and Alzheimer disease: In a previous study, Meng et al. designed the curcumin-loaded low-density lipoprotein-mimic nanostructured lipid carrier (NLC) modified with lactoferrin (Lf) to target to the brain and evaluated its effect on the progression of the AD in rats.